A federal district court denied Protega Pharmaceuticals, Inc.'s motion to dismiss retaliation claims under the False Claims Act and sex discrimination claims under New York law brought by a female key account manager who was terminated after reporting violations of the Physician Payments Sunshine Act and Anti-Kickback Statute, finding that she plausibly alleged protected whistleblowing activity and a hostile work environment where women participating in sexualized behavior were favored.
This story was produced by Bloomberg Law Automation and edited by Bloomberg Law staff.
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Log in to keep reading or access research tools and resources.
Weeks before Michigan voters headed to the polls in a closely watched primary, the Trump administration and prominent election deniers pounced on the key battleground state. They quickly revived y...